First Time Loading...

Sinovac Biotech Ltd
NASDAQ:SVA

Watchlist Manager
Sinovac Biotech Ltd Logo
Sinovac Biotech Ltd
NASDAQ:SVA
Watchlist
Price: 6.47 USD Market Closed
Updated: May 2, 2024
Section:
 

Wall Street
Price Targets

SVA Price Targets Summary
Sinovac Biotech Ltd

There are no price targets for SVA.
SVA Lowest Forecast
Wall Street Target
Not Available
SVA Average Forecast
Wall Street Target
Not Available
SVA Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Sinovac Biotech Ltd Competitors:
Price Targets
002007
Hualan Biological Engineering Inc
35% Upside
BBIO
BridgeBio Pharma Inc
85% Upside
N
4893
Noile-Immune Biotech Inc
184% Upside
Y
002675
Yantai Dongcheng Biochemicals Co Ltd
50% Upside
002007
Hualan Biological Engineering Inc
35% Upside
BBIO
BridgeBio Pharma Inc
85% Upside
N
4893
Noile-Immune Biotech Inc
184% Upside
Y
002675
Yantai Dongcheng Biochemicals Co Ltd
50% Upside
301047
Sino Biological Inc
48% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
14% Upside
IRWD
Ironwood Pharmaceuticals Inc
123% Upside
4974
Takara Bio Inc
101% Upside

Revenue
Forecast

Revenue Estimate
Sinovac Biotech Ltd

For the last 8 years the compound annual growth rate for Sinovac Biotech Ltd's revenue is 49%. The projected CAGR for the next 8 years is -33%.

49%
Past Growth
-33%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Sinovac Biotech Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Sinovac Biotech Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
SVA intrinsic value, competitors valuation, and company profile.
DCF Valuation
SVA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SVA stock valuation using valuation multiples.
Wall Street Estimates
SVA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SVA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SVA's stock price target?
Not Available

SVA doesn't have any price targets made by Wall Street professionals.

What is Sinovac Biotech Ltd's Revenue forecast?
Projected CAGR
-33%

For the last 8 years the compound annual growth rate for Sinovac Biotech Ltd's revenue is 49%. The projected CAGR for the next 8 years is -33%.

ALPHA SPREAD
Join more than 133,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.